PDL BioPharma, Inc. http://www.alacrastore.com/company-snapshot/PDL_BioPharma_Inc-1059194 Saturday, July 26, 2008 1:48:41 PM 1059194 PDL BioPharma, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/MW-0001-26742513newstex/MW-0001-26742513xml REDWOOD CITY, CA, Jul. ##, #### (Marketwire delivered by Newstex) -- REDWOOD CITY, CA -- (MARKET WIRE) -- ##/##/## -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced the appointment of Gary A. Lyons to the company's board of directors....090000000901500004000000040160000401600804002000040020011300000013002000130020057/17/2008 5:05:20 PM1800000018007000MarketwireMW-0001-26742513PROTEIN DESIGN LABS INCPDLINewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1821795ccbn/T1821795norm...Good afternoon, and welcome to the PDL BioPharma's Investor Community Conference Call. Today's call is being recorded. For opening remarks and introductions, I would now like to turn the call over to Ms. Amy Knoefler, PDL's Head of Corporate and Investor Relations. Please go ahead. ... 7/16/2008 5:11:12 PMPDL BioPharma, Inc.54.0000PDL BioPharma Conference CallPDLI5:30PM ETTranscriptT1821795Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1821795ccbn/B1821795norm...Co. declared a special cash dividend of $#.## per share of common stock to stockholders of record on ##/##/##. Board has decided to separate Co.'s biotech operations and assets from antibody humanization royalty assets. ... 7/16/2008 5:10:56 PMPDL BioPharma, Inc.54.0000PDL BioPharma Conference CallPDLI5:30PM ETBriefB1821795Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/bir/241479bir/241479normPDL BioPharma Inc.Protein Design Labs Inc.United StatesManufacturing: Manufactures biotech and biological products.283632541417EIPDLI7/11/2008 6:18:18 AM241479Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/newstex/MW-0001-25628998newstex/MW-0001-25628998xml REDWOOD CITY, CA, May ##, #### (Marketwire delivered by Newstex) -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced changes to its board of directors. L. Patrick Gage, Ph.D. has resigned as a director of PDL due to differences...09000000090150000700000007005000040000000400200004002001040020060401600004016008130000001300200013002005130100001301000507003000070030015/29/2008 6:06:04 PM1800000018007000MarketwireMW-0001-25628998PROTEIN DESIGN LABS INCKAREN A DAWESL PATRICK GAGELAURENCE JAY KORNPDLINewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-25134911newstex/MW-0001-25134911xml REDWOOD CITY, CA, May #, #### (Marketwire delivered by Newstex) -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the quarter ended March ##, ####. The results of the company's commercial and cardiovascular...07000000070050000700300007003001070010000700100407001005070140000701400807014009070140120400000004002000040020060400200104016000040160180401603104016001130000001300100013001002130100001301000513002000130020050200000002002000020020080100000001010000010100015/8/2008 7:06:46 PM18000000180200001800400018018000180070001900000019001000MarketwireMW-0001-25134911PROTEIN DESIGN LABS INCPDLINewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-24416805newstex/MW-0001-24416805xml REDWOOD CITY, CA, Apr. ##, #### (Marketwire delivered by Newstex) -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) announced today that its board of directors has: -- declared a special cash dividend of $#.## per share of common stock,...0400000004019000070000000700500004002000040020010400200604016000040160470401603104016048040160010401000004010010130000001300200013002005130100001301000507003000070030010200000002002000020020084/10/2008 5:06:11 PM1800000018012000180200001801800018008000MarketwireMW-0001-24416805PROTEIN DESIGN LABS INCKAREN A DAWESPDLINewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1788056ccbn/B1788056norm...PDLI reported that for the past several months, Board of Directors and management have undertaken strategic process whereby Co. with assistance of advisors solicited interest in purchase of PDLI either as a whole or of its key assets.... 3/5/2008 2:12:00 PMPDL BioPharma54.0000EditedPDL BioPharma Conference Call SummaryPDLI8:30am ETBriefB1788056Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1788056ccbn/T1788056norm...Good morning and welcome to PDL BioPharma's investor community conference call. Today's call is being recorded. For opening remarks and introductions I would now like to turn the call over to Ms. Amy Knoefler, PDL's head of corporate and investor relations. Please go ahead. ... 3/5/2008 12:12:00 PMPDL BioPharma54.0000FinalPDL BioPharma Conference Call TranscriptPDLI8:30am ETTranscriptT1788056Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1636535ccbn/T1636535norm8/29/2007 12:13:00 AMPDL BioPharma54.0000FinalPDL BioPharma Strategic Update TranscriptPDLI5:15pm ET...Good day; at this time, I would like to welcome everyone to the PDL BioPharma Investor Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. [OPERATOR INSTRUCTIONS]. Thank you; Ms. Knoefler, you may begin your conference. ... TranscriptT1636535Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1636535ccbn/B1636535norm8/28/2007 9:11:00 PMPDL BioPharma54.0000EditedPDL BioPharma Strategic Update SummaryPDLI5:15pm ET...Co. reported that it has created a simpler and more focused new path for PDLI. Co. is terminating the ongoing Phase III program for Nuvion in IV steroid refractory ulcerative colitis. Mark McDade has decided to step down as CEO. Co. has suspended financial guidance for ####. ... BriefB1636535Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1606054ccbn/B1606054norm8/1/2007 9:15:00 PMPDL BioPharma54.0000EditedQ2 2007 PDL BioPharma Earnings Conference Call SummaryPDLI4:30pm ET...This increase was driven by record royalty revenues and continued growth in product sales of Cardene, acute antihypertensive franchise. ... BriefB1606054Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1606054ccbn/T1606054norm8/1/2007 6:15:00 PMPDL BioPharma54.0000FinalQ2 2007 PDL BioPharma Earnings Conference Call TranscriptPDLI4:30pm ET...Good day, and welcome to the PDL BioPharma second quarter financial results conference call. (OPERATOR INSTRUCTIONS) Today's call is being recorded. For opening remarks and introductions, I would now like to turn the call over to Ms. Ami Knoefler, PDL's Head of Corporate and Investor Relation. Please go ahead. ... TranscriptT1606054Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/srp/25493srp/25493norm... ##### Incorporated:DelawareWeb Site: www.pdl.comSIC Classification: Biological Products, Except Diagnostic Substances (####) Business Description: PDL BioPharma, Inc. is a recognized leader in the discovery and development of humanized monoclonal antibodies for the treatment of disease. The company's key areas of disease focus include oncology and inflammatory and autoimmune diseases. The company has several humanized antibodies in clinical development for inflammatory bowel disease, psoriasis and asthma. The company is fully integrated from research through clinical development, and it conducts multiple activities in support of the clinical development program, including pre-clinical studies, process development, and antibody manufacturing. Indices:Russell ####, Russell ####, S&P ### ... 2549369329Y104PDLI10/6/2006 12:31:00 PM25493Credit & Investment ResearchSharkRepellent.net